<DOC>
	<DOCNO>NCT00003751</DOCNO>
	<brief_summary>RATIONALE : Penicillamine may stop growth glioblastoma stop blood flow tumor . A diet low copper may interfere growth brain tumor cell . Radiation therapy use high-energy x-rays damage tumor cell . Combining therapy may effective treat glioblastoma . PURPOSE : Phase II trial study effectiveness penicillamine , low copper diet , radiation therapy treat patient newly diagnose glioblastoma .</brief_summary>
	<brief_title>Penicillamine , Low Copper Diet , Radiation Therapy Treating Patients With Glioblastoma</brief_title>
	<detailed_description>OBJECTIVES : I . Determine effect penicillamine copper reduction survival time progression adult newly diagnose glioblastoma . II . Determine effect penicillamine reduction serum copper patient . III . Determine whether penicillamine reduces tumor volume , vascularity , invasion , edema patient . OUTLINE : Patients receive oral penicillamine follow schedule : Week 1 : daily Week 2 : two time daily Week 3 : three time daily Week 4 : four time daily Week 5 end study : increase dose four time daily . Patients also receive oral pyridoxine daily maintain low copper diet ( great 0.5 mg/day ) . This regimen continue 2 year absence disease progression unacceptable toxicity . Radiotherapy administer 6 week , begin day 1 penicillamine therapy . Patients follow every month ( MRI every 2 month ) death . PROJECTED ACCRUAL : A total 40 patient accrue study .</detailed_description>
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Copper</mesh_term>
	<mesh_term>Penicillamine</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically prove supratentorial grade IV astrocytoma ( glioblastoma multiforme ) PATIENT CHARACTERISTICS : Age : 18 Performance status : Karnofsky 60100 % Life expectancy : At least 2 month Hematopoietic : WBC least 3000/mm3 Absolute neutrophil count least 1500/mm3 Platelet count least 100,000/mm3 Hemoglobin least 10.0 g/dL No serious blood dyscrasia Hepatic : Bilirubin great 2.0 mg/dL AST ALT great 4 time upper limit normal ( ULN ) Albumin least 3.0 g/dL PT PTT great 1.5 time ULN No liver failure Renal : Creatinine great 1.7 mg/dL OR BUN great 40 mg/dL No renal failure Other : Not pregnant nursing Fertile patient must use effective contraception No serious infection No concurrent serious medical illness No allergy penicillin history serious reaction penicillamine No prior malignancy within past 5 year except curatively treat carcinoma situ basal cell skin cancer PRIOR CONCURRENT THERAPY : Biologic therapy : No prior immunotherapy brain tumor No prior biologic therapy brain tumor , include : Immunotoxins Immunoconjugates Antisense Peptide receptor antagonist Interferons Interleukins Tumor infiltrate lymphocyte Lymphokine activate killer cell Gene therapy No concurrent growth factor ( e.g. , filgrastim epoetin alfa ) Chemotherapy : No prior chemotherapy brain tumor Endocrine therapy : Must stable corticosteroid regimen least 1 week ( least 5 day ) No prior hormonal therapy brain tumor Radiotherapy : No prior radiotherapy brain tumor Surgery : Recovered prior surgery Other : No concurrent investigational agent No concurrent gold compound ( auronofin , gold sodium thiomalate ) No concurrent herbal dietary supplement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>adult glioblastoma</keyword>
	<keyword>adult giant cell glioblastoma</keyword>
	<keyword>adult gliosarcoma</keyword>
</DOC>